NA
HQL

NewEdge Advisors’s abrdn Life Sciences Investors HQL Stock Holding History

NewEdge Advisors’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$404K Sell
20,165
-3,623
-15% -$64K ﹤0.01% 2283
2026
Q1 		$387K Buy
23,788
+3,562
+18% +$59.5K ﹤0.01% 2168
2025
Q4 		$339K Sell
20,226
-6,656
-25% -$112K ﹤0.01% 2225
2025
Q3 		$417K Sell
26,882
-7,308
-21% -$100K ﹤0.01% 1946
2025
Q2 		$438K Buy
34,190
+1,690
+5% +$20.8K ﹤0.01% 1773
2025
Q1 		$412K Buy
32,500
+9,785
+43% +$133K ﹤0.01% 1694
2024
Q4 		$298K Sell
22,715
-1,201
-5% -$17.3K ﹤0.01% 1884
2024
Q3 		$361K Sell
23,916
-3,827
-14% -$57.9K ﹤0.01% 1677
2024
Q2 		$393K Buy
27,743
+2,779
+11% +$37.6K ﹤0.01% 1556
2024
Q1 		$340K Buy
24,964
+2,463
+11% +$34.1K ﹤0.01% 1572
2023
Q4 		$314K Sell
22,501
-3,407
-13% -$41.9K ﹤0.01% 1531
2023
Q3 		$323K Sell
25,908
-4,994
-16% -$65.7K ﹤0.01% 1388
2023
Q2 		$418K Buy
30,902
+1,817
+6% +$25.1K ﹤0.01% 1276
2023
Q1 		$401K Buy
29,085
+861
+3% +$12.3K 0.01% 1208
2022
Q4 		$378K Buy
28,224
+130
+0.5% +$1.88K 0.01% 902
2022
Q3 		$384K Buy
28,094
+1,564
+6% +$23.4K 0.01% 1085
2022
Q2 		$378K Buy
26,530
+2,431
+10% +$36.7K 0.01% 1102
2022
Q1 		$398K Buy
24,099
+9,500
+65% +$164K 0.01% 901
2021
Q4 		$281K Buy
+14,599
New +$294K ﹤0.01% 1360

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

NewEdge Advisors's HQL Position: Q2 2026 in Review

NewEdge Advisors reduced its abrdn Life Sciences Investors (HQL) stake by 15% in Q2 2026, selling an estimated $64K and leaving 20,165 shares worth $404K. The position accounts for ﹤0.01% of the portfolio, ranked #2283.

NewEdge Advisors first reported a position in HQL in Q4 2021 and has held it in 19 quarters since. The position peaked at $438K in Q2 2025. 83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

  • NewEdge Advisors held 20,165 shares of abrdn Life Sciences Investors worth $404K as of Q2 2026.
  • NewEdge Advisors sold 3,623 abrdn Life Sciences Investors shares in Q2 2026, an estimated $64K.
  • abrdn Life Sciences Investors made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #2283 holding.
  • NewEdge Advisors first reported a position in abrdn Life Sciences Investors in Q4 2021 and has held it in 19 quarters since.
  • NewEdge Advisors's abrdn Life Sciences Investors position peaked at $438K in Q2 2025.
  • 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.